摘要
目的通过观察硫酸镁联合β受体激动剂治疗支气管哮喘患儿的疗效,探讨硫酸镁联合β受体激动剂治疗支气管哮喘的作用。方法将56例支气管哮喘患儿随机分成两组,对照组给予β受体激动剂治疗,观察组在对照组治疗的基础上加用硫酸镁治疗,比较治疗疗效。结果 56例患儿临床症状得到不同程度缓解,对照组和治疗组治疗后比较有高度显著差异性(P<0.01)。结论硫酸镁联合β受体激动剂治疗支气管哮喘患儿是较为有效的方法,值得临床推广应用。
Objective To observe the efficacy of the children with bronchial asthma treated by magnesium sulfate and β agonist and explore the effection of magnesium sulfate β agonist to bronchial asthma. Methods All 56 patients with bronchial asthma were randomly divided into two groups. Control group was given β -receptor agonist. Observation group was treated with magnesium sulfate based on the use of β -receptor agonist. Compared the treatment efficacy. Results Clinical signs and symptoms of 56 cases were eased with varying degrees, the efficacy between control group and treatment group had significant differences through the statistical analysis （ P 〈 0.01 ）. Conclusion β -receptor agonists jointed with magnesium sulfate in asthmatic children is a more effective method and is worthy of clinical application.
出处
《中国现代医生》
2011年第24期93-94,96,共3页
China Modern Doctor
关键词
硫酸镁
Β受体激动剂
支气管哮喘
Magnesium sulfate
β -receptor agonist
Bronchial asthma
